Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date Location
ZymoGenetics Rival Emerges, Omeros IPO Casts Shadow, Microsoft’s HealthVault Seeks Users, & More Seattle Area Life Sciences News Luke Timmerman 10/29/09 Seattle
Zymo Gets $70M for Starting Trial Luke Timmerman 10/27/09 Seattle
ZymoGenetics’ Former Medical Boss Leads Rival Startup, ProFibrix, With Drug For Bleeding Luke Timmerman 10/26/09 Seattle
AVI Settles In, ZymoGenetics MS Drug Fails, Dendreon’s FDA Filing Set for Mid-November & More Seattle-Area Life Sciences News Luke Timmerman 10/01/09 Seattle
ZymoGenetics Partner Halts Multiple Sclerosis Trials After Drug Fails Luke Timmerman 09/28/09 Seattle
Biotech Pioneer Steve Gillis on Life as a VC, How Today’s Entrepreneurs Can Make It, and Seattle’s Future in Life Sciences (Part 1) Luke Timmerman 09/23/09 Seattle
The Seattle Biotech Survival Index: Companies Bounce Back in Mid-2009 Luke Timmerman 09/22/09 Seattle
Novo Nordisk’s Historic Mistake is Seattle’s Future Gain, Says Novo CEO Luke Timmerman 09/18/09 Seattle
Omeros Moves Closer to IPO, Zymo Drug Fails Arthritis Trials, Uptake Medical Gets $3.4M, & More Seattle-Area Life Sciences News Luke Timmerman 09/17/09 Seattle
Zymo Drug Fails Arthritis Trials Luke Timmerman 09/10/09 Seattle
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News Luke Timmerman 08/27/09 Seattle
Targeted Genetics’ Legacy: No Cures, But a Generation of Seattle Biotechies Luke Timmerman 08/25/09 Seattle
ZymoGenetics, Citing Two Patient Deaths, Builds Up Ammunition for Case Against Rival Luke Timmerman 08/20/09 Seattle
ZymoGenetics Plays Hardball, Asks FDA to Pull Competing Drug Off Market Because of Safety Luke Timmerman 08/20/09 Seattle
AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News Luke Timmerman 08/06/09 Seattle
Zymo Gets $6M in Q2 Recothrom Sales Luke Timmerman 08/03/09 Seattle
Dendreon May Not Survive Its Success: Q&A with Founder Chris Henney, Part 1 Luke Timmerman 07/27/09 Seattle
ZymoGenetics Picks Up Mojo, Dendreon Looks Southeast, Cell Therapeutics Raises Dough & More Seattle-Area Life Sciences News Luke Timmerman 07/23/09 Seattle
ZymoGenetics Picks Up Some of Human Genome Sciences’ Mojo With Lupus Drug Luke Timmerman 07/21/09 Seattle
Johnson & Johnson, TB Alliance Form Partnership to Push New TB Drug Through Clinic Luke Timmerman 06/17/09 Seattle
Cell Therapeutics Shares Boom, Vulcan’s Breast Cancer Bombshell, Microsoft Buys Rosetta Assets, & More Seattle-Area Life Sciences News Luke Timmerman 06/04/09 Seattle
ASCO Weekend Recap: OncoGenex, Seattle Genetics, Vulcan-Backed BiPar Show Off Cancer Drug Results Luke Timmerman 06/01/09 Seattle
ZymoGenetics Kidney Cancer Drug Shrinks, Stabilizes Tumors in Sickest Patients Luke Timmerman 05/31/09 Seattle
Vulcan’s Biotech Windfall, BiPar Sciences, Sparks “Fundamental” Cancer Advance Luke Timmerman 05/22/09 Seattle
NKT Therapeutics Aims For Severe Asthma, Targeting Natural Killer T Cells Ryan McBride 05/18/09 Boston
ASCO Preview: Seattle Genetics, ZymoGenetics, Trubion & Other Seattle Biotechs Offer Peeks at Cancer Drug Results Luke Timmerman 05/15/09 Seattle
Targeted Genetics Faces Extinction, Cell Therapeutics Unloads Debt, Dendreon Raises $221M, & More Seattle-Area Life Sciences News Luke Timmerman 05/14/09 Seattle
Zymo Melanoma Drug Shrinks Tumors Luke Timmerman 05/13/09 Seattle
Dendreon’s Hiring Binge, Calistoga’s Venture Round, ZymoGenetics Unloads Drugs, & More Seattle-Area Life Sciences News Luke Timmerman 05/07/09 Seattle
ZymoGenetics Drug Sales Still Slumping After Full Year on Market Luke Timmerman 05/05/09 Seattle
Page 1 of 4 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.